Literature DB >> 24661792

A fatal case of atrioesophageal fistula following radiofrequency ablation of left atrium and pulmonary veins for atrial fibrillation.

W R A S Rajapaksha1, Kristopher S Cunningham2, Toby H Rose3.   

Abstract

Atrial fibrillation (AF) is associated with significant morbidity and mortality. Hemodynamic compromise and formation of thrombi within the fibrillating atrium or atrial appendage can occur. Surgical treatment aims to eliminate dysrhythmia-triggering foci in the pulmonary veins and posterior left atrium by radiofrequency ablation techniques using ohmic heat. As medical treatment may be ineffective, radiofrequency catheter ablation is increasingly being used by interventional cardiac electrophysiologists for AF. Serious complications have been observed among patients who have undergone radiofrequency ablation, atrioesophageal fistula being a very rare example. This case describes a 43-year-old man who died after the development of an atrioesophageal fistula following radiofrequency ablation of the left atrium and pulmonary veins for treatment of AF.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Atrioesophageal fistula; Radiofrequency ablation

Mesh:

Year:  2014        PMID: 24661792     DOI: 10.1016/j.carpath.2014.02.004

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  2 in total

Review 1.  Treatment strategy for treating atrial-esophageal fistula: esophageal stenting or surgical repair?: A case report and literature review.

Authors:  Bing Zhou; Xue-Jiang Cen; Lin-Yan Qian; Jie Pang; Hai Zou; Ya-Hui Ding
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

2.  Management of Atrio-Esophageal Fistula Following Left Atrial Ablation.

Authors:  Tariq Yousuf; Hesam Keshmiri; Zachary Bulwa; Jason Kramer; Hafiz Muhammad Sharjeel Arshad; Rasha Issa; Daniel Woznicka; Paul Gordon; Pierre Abi-Mansour
Journal:  Cardiol Res       Date:  2016-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.